Category: Risperdal Lawsuits

Risperdal Lawsuit Bars Claims for Punitive Damages

Risperdal Lawsuit Update: Court Conference Scheduled for July 15, 2014

Audet & Partners, LLP reports that hundreds of Risperdal lawsuits now pending in Pennsylvania state courts are moving forward.  A conference is next scheduled for July 15, 2014, at which the parties will further discuss the[...]

Whistleblower Award

Whistleblower Lawsuit Against Omnicare Nets $124 Million for Federal Government

The Federal government has accepted a $124 million settlement from Omnicare to resolve several claims initiated by company employees who reported illegal kickbacks and other improprieties to regulators.  Omnicare is the largest provider of pharmaceuticals and[...]

Risperdal Punitive Damages

Risperdal Off-Label Prescriptions May Expose Johnson & Johnson to Punitive Damages

Plaintiffs in consolidated Risperdal lawsuits now pending in Pennsylvania have argued that a New Jersey statute barring punitive damages in lawsuits brought involving FDA-approved drugs does not apply when the injuries alleged result from off-label or[...]

Risperdal Lawsuit Bars Claims for Punitive Damages

Risperdal Lawsuits Time Barred, Argues Johnson & Johnson

Janssen Pharmaceuticals, a division of Johnson & Johnson  that manufactured and marketed the antipsychotic drug Risperdal to adolescent males, asked a Pennsylvania court in a Motion for Summary Judgment dated May 19, 2014, to hold that[...]

Risperdal Birth Defect Lawsuit Update

Audet & Partners, LLP reports that consolidated Risperdal birth defect lawsuits now being heard in Philadelphia Court of Common Pleas (Risperdal Litigation, Case No. 100300296) are moving forward.  Issues related to the litigation against Johnson &[...]

Risperdal Lawsuit Update

Risperdal Class Action FAQs

Audet and Partners, LLP is now representing several males who have been diagnosed with Gynecomastia after having taken the antipsychotic drug Risperdal.  If you have suffered this or a similar injury, you may be wondering whether[...]

Whistleblower Award

Whistleblower Lawsuits On The Rise

Whistleblower claims, or "qui tam" lawsuits, brought under the federal False Claims Act, increased to 753 in 2013, an increase of almost 20% over the previous year.*  These claims resulted in aggregate net recoveries to the[...]

Ripserdal Gynecomastia Lawsuits

Risperdal Gynecomastia Link Detailed in New Study

New research presented at the American Association for Geriatric Psychiatry (AAGP) 2014 Annual Meeting appears to substantiate the link between Johnson & Johnson’s drug Risperdal and gynecomastia, the development of breasts in men and young boys[...]

Older